Search

everythinglearnresearchcommunity

for

Search:↓

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Dutasteride is a safe and effective treatment for hair loss.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Dutasteride injections can help treat hair loss in men and women.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Hair regrowth improved, but quality of life did not.

A new treatment for hair loss shows promise with fewer side effects.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Azathioprine may be an effective treatment for severe hair loss.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.